SCHEMBL6664040

SCHEMBL6664040

OCC#CCC1(Cc2cccs2)CCC1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSC P53634 2/20 0.36
HSD11B1 P28845 7/20 0.35
HPGD P15428 3/20 0.32
MAPT P10636 1/20 0.32
CYP2C19 P33261 1/20 0.32
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
KMT2A Q03164 1/20 0.31
MGAM O43451 1/20 0.31
SI P14410 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5507377 0.81 HSD11B1 (0.39) CTSCHSD11B1HPGDMAPTCYP2C19
SCHEMBL10984814 0.70 TAAR1 (0.42) HPGDMAPTCYP2C19ADRA2AADRA2B
SCHEMBL6657473 0.70 CTSC (0.35) CTSCHSD11B1HPGDMAPTCYP2C19
SCHEMBL28708090 0.67 TAAR1 (0.39) HSD11B1HPGDMAPTCYP2C19ADRA2A
Acetic Acid SCHEMBL29201773 0.67 CYP2C19 (0.44) HSD11B1HPGDMAPTCYP2C19CYP3A4
SCHEMBL30960368 0.67 GRIN2B (0.44) HSD11B1HPGDMAPTCYP2C19ADRA2A
SCHEMBL8285020 0.66 HSD11B1 (0.47) HSD11B1HPGDMAPTKMT2ANPC1
SCHEMBL27593899 0.64 HSD11B1 (0.40) HSD11B1HPGDMAPTCYP2C19TAAR1
SCHEMBL4021034 0.64 HSD11B1 (0.39) CTSCHSD11B1HPGDMAPTCYP2C19
SCHEMBL17033075 0.63 HSD11B1 (0.43) HSD11B1MAPTCYP2C19ADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1442033-A1 OMEGA-CYCLOALKYL 17-HETEROARYL PROSTAGLANDIN E2 ANALOGS AS EP2-RECEPTOR AGONISTS Allergan, Inc. (US) 2004-08-04 EP disclosed
EP-1438104-A1 CO-CYCLOALKYL 17-HETEROARYL PROSTAGLANDIN E2 ANALOGS AS EP2-RECEPTOR AGONISTS Allergan, Inc. (US) 2004-07-21 EP disclosed
WO-2003040126-A1 φ-CYCLOALKYL 17-HETEROARYL PROSTAGLANDIN E2 ANALOGS AS EP2-RECEPTOR AGONISTS ALLERGAN, INC. (US) 2003-05-15 WO disclosed
WO-2003037433-A1 CO-CYCLOALKYL 17-HETEROARYL PROSTAGLANDIN E2 ANALOGS AS EP2-RECEPTOR AGONISTS ALLERGAN, INC. (US) 2003-05-08 WO disclosed